# Eyenuk

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/eyenuk
- **Dataset:** https://optimly.ai/brand/eyenuk.json
- **Markdown:** https://optimly.ai/brand/eyenuk/llms.txt
- **Official website:** https://eyenuk.com
- **Slug:** eyenuk
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** Eyenuk's EyeArt is the first and only FDA 510(k)-cleared autonomous AI for simultaneous detection of mtmDR and vtDR, boasting high accuracy (96% sensitivity, 88% specificity for mtmDR; 97% sensitivity, 90% specificity for vtDR). It's a multidisease platform expanding to detect AMD, glaucoma, and predictive biomarkers, is compatible with multiple retinal camera models, and operates without typically needing patient dilation.
Source: Brand's website (https://eyenuk.com) · 2026-10-04

- **Description:** Eyenuk provides the first and only FDA 510(k)-cleared autonomous AI (powered by EyeArt) that detects vision-threatening diabetic retinopathy. The solution offers immediate health insights through non-invasive retinal imaging, designed for early detection, triage, and monitoring of eye diseases like DR, AMD, and glaucomatous signs without requiring specialists for initial screening.
Source: Brand's website (https://eyenuk.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - EyeArt
  - an autonomous AI system for retinal screening that detects more than mild and vision-threatening diabetic retinopathy (mtmDR/vtDR)
  - Age-related Macular Degeneration (AMD)
  - and glaucomatous signs.
Source: Brand's website (https://eyenuk.com) · 2026-10-04

- **Pricing:** The system enables healthcare providers to generate immediate revenue by billing CPT 92229 for autonomous, specialist-free AI retinal screening, aligning with value-based care models.
Source: Brand's website (https://eyenuk.com) · 2026-10-04

## Audience

- **Target industry:** Healthcare providers including primary care, endocrinology, optometry, ophthalmology, and large public health screening programs. It serves clinical settings in the US and globally.
Source: Brand's website (https://eyenuk.com) · 2026-10-04

Page last updated 2026-10-17.